跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Paracoxcy - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Paracoxcy
Approved
STANDARD
Paracoxcy
Wanbang Biopharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
708c2d42500d7b5f
Company
Wanbang Biopharmaceuticals
Type
Standard
Approval Details
Approval Id
708c2d42500d7b5f
Drug Approval Philippines Name
Paracoxcy
Product Name
Paracoxcy
Registration Number
DRP-13338-01
Brand Name
Paracoxcy
Generic Name
Parecoxib (as sodium)
Dosage Form
Lyophilized Powder for Injection (IM/IV)
Dosage Strength
40 mg
Manufacturer
Wanbang Biopharmaceuticals
Importer
AMB HK Enterprises Inc
Distributor
Cyden Medicale Trading Inc.
Company Detail Path
/organization/wanbang-biopharmaceuticals
Issuance Date
01 August 2023
Expiry Date
30 January 2028
Pharmacologic Category
Selective Cox-2 Inhibitor (Coxib)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
708c2d42500d7b5f
Type
Standard
Back to Philippines FDA Approvals